Loop Capital analyst Cody Acree lowered his price target for Silicon Labs to $90 from $110, while reiterating a Hold rating on the shares. Given the company's size, at just under a $1B run-rate, the analyst believes Silicon Labs has many company specific drivers in IoT, Infrastructure and Automotive that should help insulate it to a degree from the broad macro semi demand slowdown being seen by Texas Instruments (TXN) and likely many other chip companies. However, Acree does not expect Silicon Labs' specific drivers to fully offset the macro caution in OEM build rates and the likelihood that OEMs and distributors will be working to maintain very lean inventories, particularly given that chip industry delivery lead times remain at low levels.

Baird raised the firm's price target on Texas Instruments to $175 from $125 and keeps a Neutral rating on the shares. The firm said any unexpected/incremental softening in demand would likely trigger price cuts given the current environment of low lead times and excess capacity, and the shape of 2H recovery will be critical in addressing inventory levels.

Barclays analyst Tom O'Malley lowered the firm's price target on Silicon Labs to $120 from $140 and keeps an Equal Weight rating on the shares. The company's revenue is rebounding off of December bottom and a recovery is underway, but operating expenditures ticked up and the margin miss make return to profitability a bit of a longer road, the analyst tells investors in a research note.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

As previously reported, Summit Insights downgraded Silicon Labs to Hold from Buy. While stating that Silicon Labs' March quarter results and June quarter outlook "clearly support our view of a recovery from the industry downturn and inventory correction after an extended period of customers' double ordering," the firm also believes a recovery is now priced into the share price and expects the stock to be an inline performer.

TD Cowen analyst Joshua Buchalter raised the firm's price target on Texas Instruments to $175 from $160 and keeps a Hold rating on the shares. The firm said the print wasn't great but an important improvement and positive indicator on stability for the group. That said, numbers still need to move meaningfully higher to build medium-term valuation support or material buyback growth.

BofA raised the firm's price target on Texas Instruments (TXN) to $190 from $175 and keeps a Neutral rating on the shares. TI's small Q1 beat and inline but sequentially rising Q2 sales guidance, "while modest, potentially marks a recovery inflection in industrial chip demand," with positive read-across for U.S. peers such as Analog Devices (ADI), Microchip (MCHP), NXP Semiconductors (NXPI) and On Semiconductor (ON), the analyst tells investors. However, despite an expected recovery, TI's sustained high capex intensity could keep reported calendar year 2024-26 pro-forma EPS below $6 per share, the analyst added.